Chemoinformaics analysis of 18-beta-glycyrrhetinic-acid
Molecular Weight | 206.197 | nRot | 0 |
Heavy Atom Molecular Weight | 196.117 | nRig | 31 |
Exact Molecular Weight | 206.058 | nRing | 2 |
Solubility: LogS | -4.076 | nHRing | 1 |
Solubility: LogP | 5.477 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
nHA | 4 | APOL | 28.2459 |
nHD | 2 | BPOL | 12.6361 |
QED | 0.374 |
Synth | 3.905 |
Natural Product Likeliness | 1.651 |
NR-PPAR-gamma | 0.977 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.999 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.865 |
MDCK | 0.0000181 |
BBB | 0.048 |
PPB | 1.00211 |
VDSS | 0.571 |
FU | 0.0094357 |
CYP1A2-inh | 0.091 |
CYP1A2-sub | 0.111 |
CYP2c19-inh | 0.876 |
CYP2c19-sub | 0.178 |
CYP2c9-inh | 0.826 |
CYP2c9-sub | 0.945 |
CYP2d6-inh | 0.397 |
CYP2d6-sub | 0.472 |
CYP3a4-inh | 0.426 |
CYP3a4-sub | 0.605 |
CL | 3.085 |
T12 | 0.074 |
hERG | 0.192 |
Ames | 0.698 |
ROA | 0.739 |
SkinSen | 0.921 |
Carcinogencity | 0.173 |
EI | 0.022 |
Respiratory | 0.152 |
NR-Aromatase | 0.906 |
Antiviral | No |
Prediction | 0.687441 |